Skip to content

Clinical trials

Observational Lung Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20121
20132
20163
20172
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia3
AstraZeneca2
McMaster University2
George Washington University1
McMaster Children's Hospital1
Population Health Research Institute1
St. Joseph's Healthcare Hamilton1
Université de Sherbrooke1
XDx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases13
Lung Neoplasms4
Cystic Fibrosis3
Dyspnea3
Neoplasms2
Pulmonary Disease, Chronic Obstructive2
Pulmonary Embolism2
Respiratory Tract Diseases2
Arteriovenous Fistula1
Asthma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.